Company Encyclopedia
View More
name
Orthopediatrics
KIDS.US
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.
330.79 B
KIDS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking21/42
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-12.67%D
    • Profit Margin-20.06%D
    • Gross Margin73.92%A
  • Growth ScoreC
    • Revenue YoY19.90%B
    • Net Profit YoY-60.36%D
    • Total Assets YoY0.86%C
    • Net Assets YoY-5.83%D
  • Cash ScoreC
    • Cash Flow Margin-498.55%E
    • OCF YoY19.90%B
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreB
    • Gearing Ratio29.22%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    A leading kids safety bill has been poison pilled, supporters say

    A House committee is revisiting a leading kids online safety bill, previously stalled in the House, along with 18 other proposals. The Energy and Commerce subcommittee held a three-hour hearing to discuss these bills, including a revised Kids Online Safety Act (KOSA), which had passed the Senate but was not voted on in the House last year. The effort aims to enhance internet safety for children.

    The Verge·
    US
    KIDS
    +1.34%
    The Verge·
    US
    KIDS
    +1.34%

    OrthoPediatrics (NASDAQ:KIDS) Is Making Moderate Use Of Debt

    OrthoPediatrics (NASDAQ:KIDS) has increased its debt to $99.3m as of September 2025, with a net debt of $41.6m after accounting for cash reserves. The company has liabilities exceeding its cash and receivables by $35.2m. Despite growing its revenue by 20% to $227m, OrthoPediatrics reported an EBIT loss of $32m and negative free cash flow of $29m, making it a risky stock. Investors should monitor its balance sheet and consider the company's future earnings potential.

    Simplywall·
    US
    KIDS
    +1.34%
    Simplywall·
    US
    KIDS
    +1.34%

    OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches

    WARSAW, Ind., Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ( "OPSB" ) ...

    GlobeNewswire·
    US
    KIDS
    +1.34%
    GlobeNewswire·
    US
    KIDS
    +1.34%

    OrthoPediatrics Corporation Files Initial Statement of Beneficial Ownership for Director Kelly Laine Fischer

    OrthoPediatrics Corporation has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, listing Kelly Laine Fischer as a Director and beneficial owner. The full filing is accessible via the SEC's EDGAR system. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

    Reuters·
    US
    KIDS
    +1.34%
    Reuters·
    US
    KIDS
    +1.34%

    OrthoPediatrics Corp’s Mixed Earnings Call Review

    OrthoPediatrics Corp's recent earnings call revealed a mixed sentiment, showcasing strong growth in core segments with a 12% year-over-year revenue increase and a 56% improvement in adjusted EBITDA. However, challenges in 7D capital sales and the Latin American market, along with increased operating expenses and impairment charges, tempered the positive outlook. The company anticipates full-year revenue between $233.5 million and $234.5 million, aiming for positive cash flow in Q4 and break-even in 2026, despite short-term disruptions.

    Tip Ranks·
    US
    KIDS
    +1.34%
    Tip Ranks·
    US
    KIDS
    +1.34%
    © 2025 Longbridge｜Disclaimer